Gene · 406959
Papers3,243
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,243
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomarkers in renal cell carcinoma and their targeted therapies: a review. | Explor Target Antitumor Ther | 2023 | 37970211 | PubTator, text mining | PubMed |
| Molecular beacon decorated silver nanowires for quantitative miRNA detection by a SERS approach. | Anal Methods | 2023 | 37961002 | PubTator, text mining | PubMed |
| Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways. | Int J Mol Sci | 2023 | 37958702 | PubTator, text mining | PubMed |
| miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer. | Int J Mol Sci | 2023 | 37958677 | PubTator, text mining | PubMed |
| Longitudinal dynamics of circulating miRNAs in a swine model of familial hypercholesterolemia during early atherosclerosis. | Sci Rep | 2023 | 37935844 | PubTator, text mining | PubMed |
| A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma. | Aging (Albany NY) | 2023 | 37934582 | PubTator, text mining | PubMed |
| Circulating miRNAs signature on breast cancer: the MCC-Spain project. | Eur J Med Res | 2023 | 37925534 | PubTator, text mining | PubMed |
| MicroRNA-96-5p is negatively regulating GPC3 in the metastasis of papillary thyroid cancer. | SAGE Open Med | 2023 | 37915840 | PubTator, text mining | PubMed |
| Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus. | Lupus | 2023 | 37906972 | PubTator, text mining | PubMed |
| Pharmacogenomic Landscape of Ivermectin and Selective Antioxidants: Exploring Gene Interplay in the Context of Long COVID. | Int J Mol Sci | 2023 | 37895148 | PubTator, text mining | PubMed |
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas. | Int J Mol Sci | 2023 | 37894763 | PubTator, text mining | PubMed |
| MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens. | Biology (Basel) | 2023 | 37887044 | PubTator, text mining | PubMed |
| Relevance of micro-RNAs and their targets as a diagnostic and prognostic marker in oral squamous cell carcinoma. | J Oral Maxillofac Pathol | 2023 | 37854932 | PubTator, text mining | PubMed |
AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification. | Research (Wash D C) | 2023 | 37854295 | PubTator, text mining | PubMed |
| Vascular calcification: from the perspective of crosstalk. | Mol Biomed | 2023 | 37851172 | PubTator, text mining | PubMed |
| The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens. | Technol Cancer Res Treat | 2023 | 37849311 | PubTator, text mining | PubMed |
| Cellular signaling modulated by miRNA-3652 in ovarian cancer: unveiling mechanistic pathways for future therapeutic strategies. | Cell Commun Signal | 2023 | 37845675 | PubTator, text mining | PubMed |
| Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients. | Int Immunopharmacol | 2023 | 37844462 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application. | Diagnostics (Basel) | 2023 | 37835815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406959/papers?page=9